Historical Price Lookup
On September 15, 2022, Caladrius Biosciences and Cend Therapeutics announced the closing of their merger. The merged company now operates as Lisata Therapeutics, Inc. and trades on The Nasdaq Capital Market under the ticker symbol “LSTA”.
Week of December 4, 2023
|Date Requested||Closing Price||Volume||Split Adjustment Factor||Open Price||Day High||Day Low|
|Dec 4, 2023||$2.26||12,606||1:1||$2.19||$2.30||$2.11|
|Dec 5, 2023||$2.26||5,553||1:1||$2.32||$2.49||$2.11|
|Dec 6, 2023||$2.46||65,941||1:1||$2.30||$2.59||$2.19|
NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown. The closing price is not necessarily indicative of future price performance.
Data Provided by Refinitiv. Minimum 15 minutes delayed.